http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2564817

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't
endingPage 434
issn 1573-0646
0167-6997
issueIdentifier 3
pageRange 424-434
publicationName Investigational New Drugs
startingPage 424
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_740de7784161e9562ea387a2bc80ca49
bibliographicCitation Nishina T, Takahashi S, Iwasawa R, Noguchi H, Aoki M, Doi T. Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors. Invest New Drugs. 2018 Jun;36(3):424–34. doi: 10.1007/s10637-017-0514-4. PMID: 28965185.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e8c8dbb4f51252ebc8d094cc402ee89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d19fa3eb5c9880f7d8cd7dde2c58b3c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7224d75cf17be1334d23630bbada1ac9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57e2d9ee644d08365e955bd32a1772da
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5d68ed5d54a5b1453088eff0e733e53
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2828c1bf800af269bb88e913fc3dd67b
date 2017-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/28965185
https://doi.org/10.1007/s10637-017-0514-4
isPartOf https://portal.issn.org/resource/ISSN/1573-0646
https://portal.issn.org/resource/ISSN/0167-6997
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors
discusses http://id.nlm.nih.gov/mesh/M0018357
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M000614131
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0026502
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7512
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67462786
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9653
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638015
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11072
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2264
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2263
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID315661124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347828443

Total number of triples: 48.